We are live on ! Find out more
MSAC

Medicus Sciences Acquisition Corp

Delisted

MSAC was delisted on the 17th of February, 2023.

54 hedge funds and large institutions have $104M invested in Medicus Sciences Acquisition Corp in 2022 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 10 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

43% more capital inflows, than outflows

Capital inflows: $11.7M | Capital outflows: $8.15M

17% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 6

10% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 10

2.81% more ownership

Funds ownership: 111.35% → 114.16% (+2.8%)

0% more funds holding

Funds holding: 54 → 54 (0)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
54
Holders Change
–
Holders Change %
0%
% of All Funds
0.91%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
7
Increased
11
Reduced
10
Closed
6
Calls
$8​K
Puts
–
Net Calls
+$8​K
Net Calls Change
-⁠$5​K

MSAC Hedge Fund Activity: Q2 2022 in Review

54 of the 5,965 institutional investors tracked by Wall St. Rank reported a position in Medicus Sciences Acquisition Corp (MSAC) for Q2 2022, worth a combined $104M — up 2.6% from $101M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new MSAC positions and 6 closed out — a net gain of 1 holder — while 11 added to existing stakes and 10 trimmed.

The largest buyer was Glazer Capital, adding an estimated $4.65M. The largest seller was Affinity Asset Advisors, exiting entirely with an estimated $2.93M sold.

  • 54 institutional investors held Medicus Sciences Acquisition Corp (MSAC) as of Q2 2022, unchanged from Q1 2022.
  • Funds reported $104M of Medicus Sciences Acquisition Corp stock for Q2 2022, up 2.6% quarter-over-quarter.
  • 7 funds opened new Medicus Sciences Acquisition Corp positions in Q2 2022 and 6 closed out, a net change of +1 holder.
  • The largest Medicus Sciences Acquisition Corp buyer in Q2 2022 was Glazer Capital, an estimated $4.65M added.
  • The largest Medicus Sciences Acquisition Corp seller in Q2 2022 was Affinity Asset Advisors, an estimated $2.93M sold.

Based on aggregated 13F filings for Q2 2022.